Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin.

Harald HefterDietmar RosenthalAlexander JansenRaphaela BraunsBeyza ÜrerHans BigalkeHans-Peter HartungSven G MeuthJohn-Ih LeePhilipp AlbrechtSara Samadzadeh

Published in: Journal of neurology (2022)

Frequent injections of a complex protein-containing BoNT/A preparation are associated with significantly higher risks of developing NABs than injections with the same frequency using the complex protein-free incoBoNT/A preparation.

Keyphrases

protein protein
platelet rich plasma
ultrasound guided
molecularly imprinted
amino acid
binding protein
human health
risk assessment
climate change